Brandon Klein Brandon understands that better teams are fundamental to all of our success. As a global thought leader, ushering in the 'Future of Work' revolution, he paves the way using data + design to accelerate the Collaboration Revolution. Brandon is the Co-Founder of the software start-up, Collaboration.Ai and an active member of The Value Web, a non-profit committed to changing the way decisions are made to better impact our world. Mar 09

Futurity.org – ‘Ink’ technology prints medicine on pills

A new way of printing medicine on the outside of pills could potentially create safer, faster-acting medicines and bring new drugs to market faster.

“Some active ingredients can be dissolved in a liquid, which then behaves like normal ink, so then the process is fairly straightforward,” explains Nik Kapur, an engineering professor at the University of Leeds.

“However, when you’re working with active ingredients that don’t dissolve, the particles of the drug are suspended in the liquid, which creates very different properties and challenges for use within a printing system.

“For some tablets, you may also need higher concentrations of active ingredients to create the right dose, and this will affect how the liquid behaves.”

collaboration company, healthcare, safety, collaborative web link, crowdsourcing, ink, pharma

Brandon Klein Brandon understands that better teams are fundamental to all of our success. As a global thought leader, ushering in the 'Future of Work' revolution, he paves the way using data + design to accelerate the Collaboration Revolution. Brandon is the Co-Founder of the software start-up, Collaboration.Ai and an active member of The Value Web, a non-profit committed to changing the way decisions are made to better impact our world.